Equities

Farmsintez PAO

Farmsintez PAO

Actions
  • Price (RUB)4.90
  • Today's Change-0.10 / -2.00%
  • Shares traded6.70m
  • 1 Year change-33.13%
  • Beta--
Data delayed at least 30 minutes, as of Mar 28 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Farmsintez PAO (Farmsintez OJSC) is a Russia-based company, which is engaged in the pharmaceutical sector. The Company focuses on the medical research, development and manufacture of drugs ingredients used in oncology, gynecology, tuberculosis therapy and others. In addition, Farmsintez OAO offers chemical research services, chemical technology development and quality control services. The Company sells its products domestically, as well as abroad, including the Commonwealth of Independence State (CIS) countries. It has two wholly owned subsidiaries located in Moscow and Tallin, Estonia. As of May 21, 2011, the Company’s major shareholder was EphaG AS with a stake of 69.23%. In April 2013, the Company acquired the pharmacies of Guardum Pharmaceuticals in the U.S. state of Florida.

  • Revenue in RUB (TTM)--
  • Net income in RUB--
  • Incorporated2003
  • Employees119.00
  • Location
    Farmsintez PAOKrasnogo Kursanta25 litera ZH, BTS IT ParkSAINT PETERSBURG 188663Russian FederationRUS
  • Phone+7 8 123298080
  • Fax+7 8 123298089
  • Websitehttp://en.pharmsynthez.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Aqua Bio Technology ASA115.19m-12.81m2.04bn2.00--11.14276.7917.73-0.1599-0.15990.49380.36730.30790.65489.01---3.42-80.72-6.75-125.2966.695.57-11.12-965.980.10440.6110.7538--349.8842.041.97------
Onesano SA303.43m-120.87m2.05bn51.00--5.13--6.75-0.0812-0.08120.20830.26110.54491.986.21272,645.80-21.70-35.13-25.97--43.3852.79-39.83-32.033.40--0.0296--5.8030.63-225.52--14.67--
Lytix Biopharma AS34.02m-749.64m2.08bn----4.76--61.24-2.19-2.190.09961.280.037--0.4091---81.63-57.34-94.30-66.09-----2,203.36-4,665.04--------183.2563.94-57.01------
Poxel SA154.41m-4.42bn2.13bn30.00------13.81-1.44-1.440.0507-1.220.0597--5.4230,920.00-170.71-31.97-432.50-55.940.1294---2,861.58-101.47---4.0811.28---94.97-33.77-32.13---8.49--
Thor Medical ASA-852.49bn-47.74m2.14bn16.00--0.9225-----0.56-0.2968--1.16---------2.54-98.17-2.86-141.27------------0.00------98.20------
B.M.P. Pharma Trading AG163.80k156.78m2.15bn44.0013.71--13.7113,125.000.2990.2990.0003--------37.27--13.47--14.26-46.3425.7595,712.2032,766.20---493.86-----63.15-1.29-40.06148.97----
LungLife AI Inc3.43m-550.35m2.15bn14.00--0.9244--628.32-0.185-0.1850.00120.3250.0025--0.83152,093.86-39.89---43.59--100.00---16,064.87------0.0434---87.73---2.17------
Farmsintez PAO-100.00bn-100.00bn2.16bn119.00--2.32----------2.11-----------26.38---41.43--31.77---199.950.4603--0.5446---13.38-11.9870.25---18.15--
Arctic Bioscience AS332.05m-338.81m2.16bn----0.8934--6.50-1.60-1.601.5711.170.120.74942.87---12.24---13.38--34.42---102.04--4.00--0.0146--59.29--20.09------
Biofrontera AG2.86bn-859.46m2.18bn91.00--1.57--0.7622-0.1383-0.13830.47480.21771.081.0431.02353,444.40-32.43-15.40-53.10-19.2580.0784.31-30.06-28.831.100.12640.0813---10.5916.44-215.26--19.83--
Kancera AB0.00-561.50m2.19bn3.00---------0.786-0.7860.00--------0.00---54.82---66.21-------7,249.06-------------23.64------
Corline Biomedical AB216.59m-15.65m2.21bn13.00--2.74--10.22-0.0841-0.08411.164.340.248--10.921,925,385.00-1.79-5.71-1.92-6.24113.38128.60-7.22-38.46---89.40----6.2874.14-177.67--62.51--
Oxford Biodynamics PLC59.60m-1.27bn2.22bn45.00--3.14--37.29-0.0729-0.07290.00350.02990.03710.79870.33211,333.33-78.82-39.72-105.32-45.5252.16---2,122.75-1,324.621.72-7.500.5154--231.17-15.53-61.34---1.60--
NanoRepro AG1.39bn-657.19m2.22bn17.00--0.5192--1.60-0.5328-0.53281.143.320.28641.441.53733,372.60-13.5220.52-13.9223.1532.4635.59-47.2211.8342.54--0.0031.99-76.3587.53-112.53--56.67--
Nfl Biosciences SAS0.00-347.86m2.23bn3.00--6.72-----0.5396-0.53960.000.40970.00----0.00-80.79---125.59--------------0.0228-------149.78------
OptiBiotix Health PLC80.53m-1.54bn2.24bn3.00--1.91--27.86-0.1489-0.14890.00780.10290.04262.281.25229,700.00-81.3517.83-83.4318.6649.3154.87-1,911.88190.543.24-0.0890.00---79.3519.05-58.686.2830.03--
Data as of Mar 28 2024. Currency figures normalised to Farmsintez PAO's reporting currency: Russian Ruble RUB
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.